Reports and Discovery Program Cost Payments. Within forty-five (45) days following the end of each calendar quarter, Regeneron shall deliver electronically to Sanofi a written report setting forth in reasonable detail the Discovery Program Costs incurred by Regeneron in such calendar quarter along with an invoice therefore. Sanofi shall reimburse Regeneron for all undisputed Discovery Program Costs set forth in each report within thirty (30) days after its receipt thereof. Any disputed, unpaid Discovery Program Costs that are determined to be due and payable to Regeneron under this Agreement shall be paid with the Default Interest Rate.
Appears in 3 contracts
Sources: Discovery and Preclinical Development Agreement (Regeneron Pharmaceuticals Inc), Discovery and Preclinical Development Agreement (Regeneron Pharmaceuticals Inc), Discovery and Preclinical Development Agreement (Regeneron Pharmaceuticals Inc)